Nobel Biocare reports improved profits in a declining market
. - Revenue for the first nine months was up 3.1% to EUR 427.5 million versus prior year and down 2.4% at CER - Revenu…
. - Revenue for the first nine months was up 3.1% to EUR 427.5 million versus prior year and down 2.4% at CER - Revenu…
Fresenius Medical Care AG & Co. KGaA (the "company" or "Fresenius Medical Care"; Frankfurt Stock Exchange: FME / New Yor…